Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer.
Cabezas-Camarero, S
Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer. [electronic resource] - Oral oncology 12 2018 - 204-206 p. digital
Publication Type: Case Reports; Letter
1879-0593
10.1016/j.oraloncology.2018.10.019 doi
B7-H1 Antigen--metabolism
Bone Neoplasms--diagnostic imaging
Chemoradiotherapy
Humans
Lung Neoplasms--diagnostic imaging
Middle Aged
Nasopharyngeal Neoplasms--pathology
Nivolumab--therapeutic use
Positron Emission Tomography Computed Tomography
Treatment Outcome
Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer. [electronic resource] - Oral oncology 12 2018 - 204-206 p. digital
Publication Type: Case Reports; Letter
1879-0593
10.1016/j.oraloncology.2018.10.019 doi
B7-H1 Antigen--metabolism
Bone Neoplasms--diagnostic imaging
Chemoradiotherapy
Humans
Lung Neoplasms--diagnostic imaging
Middle Aged
Nasopharyngeal Neoplasms--pathology
Nivolumab--therapeutic use
Positron Emission Tomography Computed Tomography
Treatment Outcome